Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04271072 · ClinicalTrials.gov registry record
CSF/Serum Biomarkers in Predicting PND/Persistent Pain After Cesarean
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 81
- Enrollment target
NCT04271072 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 81 participants.
The verdict
NCT04271072 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The aim is to investigate if inflammatory biomarkers in the blood and cerebrospinal fluid (CSF) are associated with the development of perinatal depression and/or persistent pain after cesarean delivery. This study will obtain CSF and blood samples in 70 parturients. All parturients will be assessed for perinatal depression and persistent pain, and the presence/absence of these outcomes will be correlated to changes in the inflammatory biomarkers within the samples collected. If present, consistent changes in biomarkers correlating with perinatal depression or persistent pain may be utilised as a predictive tool and facilitate early treatment for these conditions.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2022-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04271072
The ClinicalTrials.gov registry entry for NCT04271072 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04271072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04271072 about?
NCT04271072 is a clinical study titled "CSF/Serum Biomarkers in Predicting PND/Persistent Pain After Cesarean". The aim is to investigate if inflammatory biomarkers in the blood and cerebrospinal fluid (CSF) are associated with the development of perinatal depression and/or persistent pain after cesarean delivery. This study will obtain CSF and blood samples in 70 parturients. All parturients will be assesse...
What is the current status of trial NCT04271072?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2020-02-01. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT04271072?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04271072?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.